| abstract |
The present invention is a peptide, particularly for use in the treatment of viral or parasitic infections, or in the treatment of tumors, having a size of less than 30 amino acids, preferably less than 20, especially 15-20 amino acids, In vitro, the present invention relates to a novel synthetic or natural peptide characterized by specifically binding to protein phosphatase type 2A holoenzyme or a subunit thereof. The invention also relates to methods for identifying the peptides and their use. |